A Study of S-740792 in Healthy Adult Study Participants

Key Inclusion Criteria: * Body mass index within the range 18.5 to 30.0 kilograms/meter squared (inclusive). Key Exclusion Criteria: * History or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrinological, hematological, or neurological disorders capable of significantly altering the absorption, metabolism, or elimination of drugs; constituting a risk when taking the study intervention; or interfering with the interpretation of data. * Participants who require medication or other treatment (for example, dietary restrictions or physical therapy). * Participants who have participated in any other clinical study involving an investigational study intervention or any other type of medical research within 28 days or 5 half-lives of that drug (if known), whichever is longer before signing of the informed consent form for this study or who are currently participating in such a study. * Positive test results of the following at screening or within 6 months prior to administration of study intervention: * hepatitis B surface antigen * hepatitis C virus antibody * serological test for syphilis * human immunodeficiency virus antigen/antibody * drug screen * alcohol screen * Participants who have used tobacco or nicotine-containing products (including electronic-cigarette, pipe tobacco, cigar, chewing tobacco, nicotine patch, and nicotine gum) within 6 months prior to admission or a positive cotinine test at screening or on admission. Note: Additional inclusion/exclusion criteria may apply, per protocol.